CL2013001470A1 - Mezcla de oligosacaridos que comprende al menos una acetil-n-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; producto alimenticio que comprende esta mezcla; y su uso para prevenir y reducir el riesgo y/o reducir la severidad y/o reducir la aparicion de alergias a alimentos y los efectos relacionados con la alergia a alimentos sobre la salud. - Google Patents

Mezcla de oligosacaridos que comprende al menos una acetil-n-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; producto alimenticio que comprende esta mezcla; y su uso para prevenir y reducir el riesgo y/o reducir la severidad y/o reducir la aparicion de alergias a alimentos y los efectos relacionados con la alergia a alimentos sobre la salud.

Info

Publication number
CL2013001470A1
CL2013001470A1 CL2013001470A CL2013001470A CL2013001470A1 CL 2013001470 A1 CL2013001470 A1 CL 2013001470A1 CL 2013001470 A CL2013001470 A CL 2013001470A CL 2013001470 A CL2013001470 A CL 2013001470A CL 2013001470 A1 CL2013001470 A1 CL 2013001470A1
Authority
CL
Chile
Prior art keywords
reduce
mixture
food
oligosaccharide
lactosamine
Prior art date
Application number
CL2013001470A
Other languages
English (en)
Inventor
Norbert Sprenger
Jean-Ricard Neeser
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44201036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001470(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2013001470A1 publication Critical patent/CL2013001470A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2013001470A 2010-11-23 2013-05-23 Mezcla de oligosacaridos que comprende al menos una acetil-n-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; producto alimenticio que comprende esta mezcla; y su uso para prevenir y reducir el riesgo y/o reducir la severidad y/o reducir la aparicion de alergias a alimentos y los efectos relacionados con la alergia a alimentos sobre la salud. CL2013001470A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10192231A EP2454948A1 (en) 2010-11-23 2010-11-23 Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Publications (1)

Publication Number Publication Date
CL2013001470A1 true CL2013001470A1 (es) 2013-12-27

Family

ID=44201036

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001470A CL2013001470A1 (es) 2010-11-23 2013-05-23 Mezcla de oligosacaridos que comprende al menos una acetil-n-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; producto alimenticio que comprende esta mezcla; y su uso para prevenir y reducir el riesgo y/o reducir la severidad y/o reducir la aparicion de alergias a alimentos y los efectos relacionados con la alergia a alimentos sobre la salud.

Country Status (18)

Country Link
US (2) US9854826B2 (es)
EP (2) EP2454948A1 (es)
CN (1) CN103582426A (es)
AU (1) AU2011333861C1 (es)
BR (1) BR112013012599A2 (es)
CA (1) CA2818015A1 (es)
CL (1) CL2013001470A1 (es)
ES (1) ES2928210T3 (es)
IL (1) IL226408A0 (es)
MX (2) MX363737B (es)
MY (1) MY163082A (es)
PH (1) PH12019500518A1 (es)
PT (1) PT2642876T (es)
RU (1) RU2581731C2 (es)
SG (1) SG190325A1 (es)
TW (1) TW201242518A (es)
WO (1) WO2012069416A1 (es)
ZA (1) ZA201304644B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
EP2658547A1 (en) 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
EP2658549B1 (en) 2010-12-31 2020-06-03 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
SG10202110503VA (en) 2010-12-31 2021-11-29 Abbott Lab Human milk oligosaccharides for modulating inflammation
SG191395A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
CA2842672A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
TW201438719A (zh) * 2012-12-18 2014-10-16 Abbott Lab 改善壓力症狀之母乳寡糖
US11160817B2 (en) * 2012-12-18 2021-11-02 Abbott Laboratories Nutritional compositions comprising neuroprotective dietary oligosaccharides
WO2015071131A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
CN105722514A (zh) * 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
EP3074020B1 (en) 2013-11-15 2022-03-30 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
WO2015077233A1 (en) * 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
RU2692488C1 (ru) 2013-12-13 2019-06-25 Нестек С.А. Использование модифицированной сладкой молочной сыворотки и детской смеси, содержащей модифицированную сладкую молочную сыворотку, для стимулирования постнатального развития центральной нервной системы и соответствующих когнитивных функций ребенка грудного возраста
EP3673909A1 (en) 2014-04-08 2020-07-01 Abbott Laboratories Nutritional compositions for use in treating enteric infection comprising human milk oligosaccharides
WO2015154256A1 (en) 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and,nutritional systems comprising them
WO2015154260A1 (en) 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
WO2015154265A1 (en) 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
JP2017520267A (ja) * 2014-07-14 2017-07-27 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ ＬＮＴ、ＬＮｎＴおよびそれらのフコシル化誘導体の生物工学的産生
EP3209308B1 (en) * 2014-10-24 2022-08-03 Evolve Biosystems Inc. Activated bifidobacteria and methods of use thereof
WO2016066175A1 (en) 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20200138838A1 (en) * 2014-10-29 2020-05-07 Glycom A/S Composition comprising hmss/hmos and use thereof
US20160243139A1 (en) * 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US10328091B2 (en) * 2014-10-31 2019-06-25 Nestec S.A. Composition comprising Fut2-dependent oligosaccharides and Lacto-N-neotetraose for use in promoting brain development and cognition
CN107404931A (zh) * 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
CN107530366A (zh) * 2015-03-31 2018-01-02 格礼卡姆股份公司 包含3’‑o‑唾液乳糖的人乳寡糖的混合物
AU2016262843B2 (en) * 2015-05-19 2021-10-14 Société des Produits Nestlé S.A. Kit-of-parts to identify mother's milk missing fucosyltransferase-2 dependent glycans and feeding doses with said glycans
WO2017021476A1 (en) * 2015-08-04 2017-02-09 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
MX2018006295A (es) 2015-12-14 2018-08-16 Nestec Sa Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
WO2017103850A1 (en) * 2015-12-15 2017-06-22 Glycom A/S Mixture of hmos
EP3407739B1 (en) 2016-01-26 2021-06-23 Société des Produits Nestlé S.A. Composition for use in the prevention and/or treatment of skin conditions and skin diseases
RU2735250C2 (ru) * 2016-01-26 2020-10-29 Сосьете Де Продюи Нестле С.А. КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 2FL И LNnT, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА
EP3407738B1 (en) * 2016-01-26 2022-02-09 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
MX2018008518A (es) 2016-03-30 2018-08-16 Nestec Sa Composiciones que comprenden colina y su uso.
CA3004046A1 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising vitamins and their use
WO2017167898A2 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions and their use
BR112018067926A2 (pt) 2016-03-30 2019-01-02 Nestec Sa composições nutricionais e seus usos
CA3003651A1 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising fatty acids and their use
SG11201803023UA (en) 2016-03-30 2018-05-30 Nestec Sa Compositions comprising minerals and their use
MX2018008522A (es) 2016-03-30 2018-08-16 Nestec Sa Composiciones que comprenden fosfolipido y su uso.
WO2018020473A1 (en) 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Dairy product and process
AU2017324759B2 (en) * 2016-09-07 2022-07-28 Société des Produits Nestlé S.A. Nutritional compositions for infants and/or young children comprising oligosaccharides
MX2019011446A (es) * 2017-05-09 2019-11-18 Nestle Sa Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños con fines de salud.
CN110573030A (zh) * 2017-05-24 2019-12-13 雀巢产品有限公司 用于增强注意力和/或降低冲动的营养组合物
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
RU2020109776A (ru) 2017-08-22 2021-09-06 Сосьете Де Продюи Нестле С.А. Дифференцированные по полу искусственные питательные композиции и содержащие их системы питания
EP3672588A1 (en) 2017-08-22 2020-07-01 Société des Produits Nestlé S.A. Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them
US20200315236A1 (en) 2017-12-22 2020-10-08 Societe Des Produits Nestle S.A. Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them
AU2018390181A1 (en) * 2017-12-22 2020-05-28 Societe Des Produits Nestle S.A. Compositions for use in the reduction of nociception in infants and young children
WO2019122123A1 (en) 2017-12-22 2019-06-27 Societe Des Produits Nestle S.A. Gender specific synthetic nutritional compositions comprising lycopene and nutritional systems comprising them
WO2019123316A1 (en) * 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception
EP3799594A4 (en) * 2018-05-23 2022-06-15 DSM IP Assets B.V. PRODUCTION OF OLIGOSACCHARIDS
MX2021003409A (es) 2018-09-25 2021-05-27 Nestle Sa Composiciones nutricionales sinteticas adaptadas para infantes de edades especificas, y sistemas nutricionales que las comprenden.
MX2021003408A (es) 2018-09-25 2021-05-27 Nestle Sa Composiciones nutricionales sinteticas especificas de genero y sistemas que las comprenden.
AU2019370713A1 (en) 2018-10-30 2021-04-01 Société des Produits Nestlé S.A. Nutritional compositions, their use in reducing metabolic stress and method of reducing metabolic stress
EP3897835A1 (en) 2018-12-19 2021-10-27 Société des Produits Nestlé S.A. Composition for preventing or reducing transepidermal water loss and improving skin barrier function
CN109731000B (zh) * 2018-12-25 2021-02-19 东北农业大学 2’-岩藻糖基乳糖的应用
EP3934656A1 (en) 2019-03-05 2022-01-12 Société des Produits Nestlé S.A. A nutritional composition for use to enhance executive function
BR112022005058A2 (pt) * 2019-10-17 2022-06-21 Nestle Sa Fórmula para bebês extensamente hidrolisada
CN114745966A (zh) * 2019-12-06 2022-07-12 雀巢产品有限公司 用于减少婴儿和幼儿的疼痛和/或疼痛感的组合物
WO2021116282A1 (en) * 2019-12-11 2021-06-17 Société des Produits Nestlé S.A. Compositions for use in the reduction of nociception and other health benefits in infants and young children
AU2020419435A1 (en) * 2019-12-30 2022-05-26 Société des Produits Nestlé S.A. Infant formula
JP2021112165A (ja) * 2020-01-20 2021-08-05 森永乳業株式会社 組成物並びに飲食品組成物、栄養組成物および調製乳
EP4228436A1 (en) * 2020-10-16 2023-08-23 Société des Produits Nestlé S.A. Nutritional composition comprising human milk oligosaccharides
EP4262439A1 (en) 2020-12-18 2023-10-25 Société des Produits Nestlé S.A. Synthetic nutritional compositions tailored for chinese infants
CN114009510A (zh) * 2021-11-24 2022-02-08 北安宜品努卡乳业有限公司 一种低致敏性婴儿羊乳基配方乳粉及其制备方法
WO2024008851A1 (en) * 2022-07-08 2024-01-11 Société des Produits Nestlé S.A. Uses of bifidobacterium longum transitional microorganism

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US6946451B2 (en) * 2002-02-04 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Insulin secretion promoter
JP4401659B2 (ja) * 2002-02-04 2010-01-20 協和発酵バイオ株式会社 インスリン分泌促進剤
AU2003251557A1 (en) * 2002-06-28 2004-01-19 Richard C. Theuer Fat compositions for infant formula and methods therefor
MXPA06006392A (es) * 2003-12-05 2007-03-15 Childrens Hosp Medical Center Composiciones de oligosacaridos y uso de estas en el tratamiento de infecciones.
RU2442438C2 (ru) 2005-02-21 2012-02-20 Нестек С.А. Смесь олигосахаридов
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
JP2009523173A (ja) * 2006-01-09 2009-06-18 チルドレンズ ホスピタル メディカル センター 様々な病気の治療用のアディポネクチン
MY149913A (en) 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
PT1993577E (pt) * 2006-03-10 2014-05-27 Nutricia Nv Uso de sacarídeos não digestivos para proporcionar a uma criança o melhor começo após o nascimento
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
PL2217246T3 (pl) 2007-11-08 2015-06-30 Nestec Sa Zastosowanie oligosacharydów zawierających n-acetylolaktozaminę do dojrzewania odpowiedzi odpornościowych u noworodków
WO2009151315A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
MY189329A (en) 2009-07-15 2022-02-04 Nutricia Nv Mixture of non-digestible oligosaccharides for stimulating the immune system
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
BR112012017978A2 (pt) 2010-01-19 2016-05-03 Abbott Lab fórmulas nutricionais contendo simbióticos
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2465508A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
EP2642876A1 (en) 2013-10-02
MX363737B (es) 2019-04-01
AU2011333861A1 (en) 2013-06-06
ES2928210T3 (es) 2022-11-16
MX2013005862A (es) 2013-07-05
EP2454948A1 (en) 2012-05-23
PT2642876T (pt) 2022-10-17
WO2012069416A1 (en) 2012-05-31
AU2011333861C1 (en) 2020-11-12
CA2818015A1 (en) 2012-05-31
TW201242518A (en) 2012-11-01
US20130251844A1 (en) 2013-09-26
RU2013128595A (ru) 2014-12-27
US9854826B2 (en) 2018-01-02
US20180110253A1 (en) 2018-04-26
US10716321B2 (en) 2020-07-21
EP2642876B1 (en) 2022-07-13
IL226408A0 (en) 2013-07-31
MX2019002953A (es) 2019-10-21
CN103582426A (zh) 2014-02-12
MY163082A (en) 2017-08-15
RU2581731C2 (ru) 2016-04-20
AU2011333861B2 (en) 2015-09-03
BR112013012599A2 (pt) 2016-07-19
PH12019500518A1 (en) 2020-09-14
ZA201304644B (en) 2018-12-19
SG190325A1 (en) 2013-06-28

Similar Documents

Publication Publication Date Title
CL2013001470A1 (es) Mezcla de oligosacaridos que comprende al menos una acetil-n-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; producto alimenticio que comprende esta mezcla; y su uso para prevenir y reducir el riesgo y/o reducir la severidad y/o reducir la aparicion de alergias a alimentos y los efectos relacionados con la alergia a alimentos sobre la salud.
CL2013001472A1 (es) Mezcla de oligosaridos que comprende 5-70% en peso de al menos un oligosacarido n-acetilado, 5-90% en peso de al menos un galacto-oligosacarido, 2-50% en peso de al menos un oligosacarido sialilado y 5-70% en peso de al menos un oligosacarido fucosilado; producto alimenticio que la comprende; y su uso para la prevencion y reduccion del riesgo y/o reduccion de la severidad y/o reduccion de la ocurrencia de alergias en alimentos.
CL2013001433A1 (es) Composicion que comprende al menos una n-acetil lactosamina, al menos un oligosacarido sialilado al menos un oligosacarido fucosilado; y su uso en la prevencion de infecciones respiratorias agudas y/o para aliviar los sintomas de dichas infecciones.
IL280294A (en) A pharmaceutical preparation containing the phytocannabinoids cannabidiol (CBD) and cannabidiol (CBD)
CL2013001436A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
CL2013001471A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado y un hidrolizado que comprende proteinas parcialmente y/o completamente hidrolizadas; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
BRPI0816133A2 (pt) Composição que emite flavorizante, dispositivo que emite flavorizante, tablete comprimido ou moldado, produto alimentício acondicionado, e, métodos para fabricar um dispositivo que emite flavorizante e uma composição que emite flavorizante.
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
CL2008000691A1 (es) Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades.
MX305105B (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
BRPI1016015A2 (pt) dispositivo médico antimicrobiano embalado que tem via útil aprimorada e métodos para produzir tal dispositivo.
CO6640246A2 (es) Forma cristalina del inhibidor sglt2 bencilbenceno
BR112013011736A2 (pt) ferramenta para separar a polpa de um miolo e uma casca de uma fruta
IL216006A (en) Processed aromatic compounds, pharmaceutical preparations including them and their use in the manufacture of pharmaceuticals
CL2014003429A1 (es) Compuestos especificos derivados de indanosulfamida; composicion farmaceutica que los comprende, utiles en el tratamiento e la epilepsia.
CL2014003015A1 (es) Procedimiento para la manufactura de bioproductos con un perfil modificado de azúcar; bio-producto; uso; y alimento que lo comprende.
CO7061069A2 (es) Glucosaminoglucanos no anticogulantes que comprenden una unidad de repetición de disacárido y su uso médico
BRPI0822829A2 (pt) Equipamento para preparar, expor e vender a varejo produtos alimentícios
WO2011076367A3 (en) Synergistic antiviral composition and use thereof
SMT201400168B (it) Composti di benzen.solfonammidi, loro procedimentodi sintesi e loro utilizzo in medicina
CL2015001180A1 (es) Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos.
AR083093A1 (es) Combinacion para reemplazo de grasas para la sustitucion parcial o total de la grasa en productos alimenticios y un producto alimenticio que la contiene
IT1397935B1 (it) Pacchetto per articoli da fumo e relativo sbozzato di cartoncino.
ES2531412T3 (es) Composición nutricional que comprende un extracto de manzana y que reduce los síntomas de alergia, especialmente en niños
BRPI0907824B1 (pt) ingrediente de oligossacarídeo, processo para produzir o mesmo e produto alimentício que o compreende